Moreover, characterized by p53 phenotype in these HCC cell lines, lobaplatin appeared to have similar cytotoxicity profiles to oxaliplatin which was active for advanced HCC patients [5,6]. The gene discussed is TP53; the disease is hepatocellular carcinoma.